Jarushka Naidoo (@DrJNaidoo) / X

Jarushka Naidoo

6,218 posts

Jarushka Naidoo

@DrJNaidoo

Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University

scholar.google.com/citations?user…

Joined March 2018

Jarushka Naidoo
@DrJNaidoo
Dec 15, 2022
It’s official 🎓🎉 Pleased to announce my new role as Academic Professor @CancerCentreIre @RCSI_Irl @Beaumont_Dublin Thanks to the village of mentors, collaborators & supporters #ASCOLDP22 @ASCO @myESMO @MSKCancerCenter @etop_ibcsg @HopkinsThoracic @JulieBrahmer @DrLizJaffee
RCSI
@RCSI_Irl
Dec 15, 2022
Prof Jarushka Naidoo @DrJNaidoo has been appointed RCSI Professor of Medical Oncology. She will lead RCSI’s innovative medical #CancerResearch team to further its growth and continue its work to translate research findings into treatments. rcsi.com/dublin/news-an… #RCSIdiscover
Jarushka Naidoo
@DrJNaidoo
Sep 22, 2020
An announcement: excited to be back home in Dublin, starting a new position at Beaumont Hospital Dublin & leading the lung cancer group in @cancertrials_ie. Looking forward to the next chapter! @Beaumont_Dublin @RCSI_Irl collaborations continue with my @HopkinsThoracic family
Jarushka Naidoo
@DrJNaidoo
Oct 6, 2024
Superb article on the secret sauce of team science, in @NatureBiotech: It takes two to think ‘Morale thrives on the encouragement we get from the feedback of someone who understands our work & it’s motivations’ Great read nature.com/articles/s4158…
42K
Jarushka Naidoo
@DrJNaidoo
Jan 30, 2022
Larotrectinib in NTRK Fusion+ NSCLC: - 20 nsclc pts from 3 early ph trials - ORR 73% (1 CR, 10 PRs) - mDOR 33.9mo; PFS 35.4mo; mOS 40.7mo NTRK may be a needle in a haystack, but if u find it- it’s a golden needle 🙏🏼 ⁦@OncoAlert⁩ #LCSM
ascopubs.org
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive...
PURPOSELarotrectinib is a highly selective and CNS-active tropomyosin receptor kinase (TRK) inhibitor that has demonstrated efficacy across TRK fusion–positive cancers, regardless of the tumor type....
Jarushka Naidoo
@DrJNaidoo
Apr 5, 2024
🔥Big News Press Release: Ph III ADRIATIC Trial meets OS & PFS Endpoints for Durva v Placebo in Limited Stage SCLC: - 730pts with LS-SCLC post cCRT - pts randomised to Durva +/- Treme post cCRT v pbo Can't wait to see the full data @OncoAlert #LCSM astrazeneca.com/media-centre/p…
24K
Jarushka Naidoo
@DrJNaidoo
Sep 16, 2024
#ESMO24 Lung mini-orals🔥 Randomised ph II trial of inhaled corticosteroids in stage III NSCLC treated with cCRT, to reduce radiation pneumonitis: - 292pts - 15% reduction in RP - no long-term steroid tox No need for ph III, could do tomorrow #ESMOAmbassadors #ESMO24 @myESMO
16K
Jarushka Naidoo
@DrJNaidoo
Mar 21, 2021
José Baselga was physician-in-chief @sloan_kettering when I was a fellow. I remember he used to say, keep a list of your 5 career goals in your top drawer. ‘Everytime anyone asks u to do something, open the drawer. If it doesn’t fit- say no- if it fits, go’ RIP to a mentor& icon
OncoAlert
@OncoAlert
Mar 21, 2021
Prof. José Baselga has passed on March 21st Dr.Baselga was an amazing oncologist& researcher who paved the way for many molecular targeted therapies in2017 was awarded the @myESMO Lifetime Achievement Award Huge loss for the Oncology Community Our thoughts are with his family
Jarushka Naidoo
@DrJNaidoo
Nov 18, 2024
'TrialGPT:' A new chatGPT for clinical trials @Nature - 3 steps: TrialGPT-Retrieval, TrialGPT-Matching, TrialGPT-Ranking - Retrieval identified 90% of suitable trials - 42% time-saving in matching a patient to a trial Like, wow @OncoAlert #LCSM
Matching patients to clinical trials with large language models
From nature.com
23K
Jarushka Naidoo
@DrJNaidoo
Oct 30, 2024
Introducing the Beaumont RCSI ICS Lung Cancer program grant, a €4.9mil investment from @IrishCancerSoc for: - Ireland’s first early detection pilot - Liquid biopsy research - Primary care research - Investigator-led KRAS/IO trials Delighted PI @myESMO @IASLC @CancerCentreIre
RTÉ News
@rtenews
Oct 30, 2024
A €4.9m lung cancer research programme funded by the Irish Cancer Society has been launched. The society said the programme marks its biggest single investment in the area of lung cancer rte.ie/news/health/20…
26K
Jarushka Naidoo
@DrJNaidoo
Jan 2, 2022
Love this beautifully clear method on how to write a scientific paper #MedTwitter @OncoAlert
Andrew M. Ibrahim MD, MSc
@AndrewMIbrahim
Aug 13, 2021
Replying to @elliotthaut @juliomayol and 5 others
How to write a scientific paper in four slides. Full guide here: surgeryredesign.com/s/WritingForIm… Lecture format here: m.youtube.com/watch?v=4P7flD…
Jarushka Naidoo
@DrJNaidoo
May 4, 2022
Excited to be ⁦@ASCO⁩ headquarters today for #ASCOLDP21 🇺🇸🇮🇪 ⁦@hemoncwarner⁩ ⁦@MGZauderer⁩ ⁦@maryam_lustberg⁩ ⁦@rachnatshroff⁩ ⁦@ErikaHamilton9⁩ ⁦@cancerassassin1⁩ ⁦@KlempnerSam⁩ ⁦@joan_schiller⁩ ⁦@tomleblancMD⁩ &more
Jarushka Naidoo
@DrJNaidoo
Mar 15, 2024
An honor to present to the US congressional cancer caucus on US-Ireland cancer research collaboration 🇺🇸🇮🇪 >50% of Irish oncologists are US-trained, & many now leaders in the field We propose to grow these links with strategic investment, & in areas of need such as lung cancer
14K
Jarushka Naidoo
@DrJNaidoo
Sep 3, 2023
It is not uncommon for clinician scientists to be questioned whether they’re ‘real doctors’ or ‘true scientists’ Both The secret to a long life as a clinician scientist is the same as a long marriage. Selective deafness Great paper @ESMO_Open @DrJonLim
Young oncologists’ perspective on the role and future of the clinician-scientist in oncology
From esmoopen.com
20K
Jarushka Naidoo
@DrJNaidoo
Mar 29, 2025
My #ELCC25 Top 3: 1. #MARIPOSA: meets OS (HR 0.75), but tox burden limits to a subset of pts? Controversial 2. #KRYSTAL7: mPFS 27.7m. Way better than I expected. One to watch 3. #Deescalation trials by @BenjaminBesseMD. Let’s be good oncologists, &good citizens Thanks @myESMO
11K